Is Krispy Kreme a Buy After Its Latest Earnings Report?
Krispy Kreme (DNUT) reported a Q3 loss of $0.08 per share, improving from 2025, with revenue at $329M, down 12.5% YoY. Adjusted EPS was $0.06, up from $0.01. The company is refranchising to cut costs and improve margins, opening 98 franchised shops this year. It raised full-year revenue guidance to $1.35B-$1.4B and lowered capex outlook. Analysts raised price targets, with Bank of America setting a $6.30 target.
How this was made

The 30-second read
Why it matters
The earnings beat and guidance raise may trigger short‑term buying, but execution risk remains.
Market read
Earnings surprise and guidance lift provide a clear catalyst for DNUT, offering a short‑term trade idea.
What to watch
Potential impact of GLP‑1 drugs on demand not yet quantified.
Background
Krispy Kreme has been in a multi‑year turnaround, cutting capex and deleveraging while expanding franchised locations.
Ticker impact
Q3 earnings surprise with loss per share of $0.08, adjusted EPS $0.06 and raised full-year revenue guidance to $1.35‑$1.40B.
likely upward pressure as the market prices in the guidance lift and improved leverage.
The earnings beat and guidance raise are fresh primary disclosures that typically drive short‑term buying.
Market effects
Improved outlook for the specialty food & beverage sector as refranchising models show profitability.
US consumer discretionary sentiment may get a modest boost.
Limited to US small‑cap investors.
Counterpoint
High leverage remains a risk; price could stall if turnaround stalls.
Key entities
- ExecutiveJoshua Charlesworth
CEO who highlighted refranchising progress.



